肝异型增生结节的研究进展

doi:10.16139/j.1007-9610.2018.03.020

摘要/Abstract

中图分类号:

R735.7

周恺乾, 周成, 王征. 肝异型增生结节的研究进展[J]. 外科理论与实践, 2018, 23(03): 286-288.

[1] Yeh SH, Chen PJ, Shau WY, et al.Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma[J]. Gastroenterology,2001,121(3):699-709.
[2] Niller HH, Ay E, Banati F, et al.Wild type HBx and truncated HBx: Pleiotropic regulators driving sequential genetic and epigenetic steps of hepatocarcinogenesis and progression of HBV-associated neoplasms[J]. Rev Med Virol,2016,26(1):57-73.
[3] Feitelson MA, Sun B, Satiroglu Tufan NL, et al.Genetic mechanisms of hepatocarcinogenesis[J]. Oncogene,2002, 21(16):2593-2604.
[4] Bosman FT, Carneiro F, Hruban RH, et al.WHO Classification of Tumours of the Digestive System[M]. 4th Edi-tion. Lyon: IARC press, 2010.
[5] 陈伶俐. 肝脏异型增生结节癌变过程的病理形态、发生机制及癌变相关microRNA的研究[D]. 上海: 复旦大学,2011.
[6] 丛文铭, 朱世能. 肝胆肿瘤病理学[M]. 上海: 上海科技教育出版社,2015.
[7] Lim JH, Kim MJ, Park CK, et al.Dysplastic nodules in liver cirrhosis: detection with triple phase helical dyna-mic CT[J]. Br J Radiol,2004,77(923):911-916.
[8] Bansal N, Vij V, Rastogi M.Different nodules identified during liver explant gross examination: relevance and need for sectioning-experience from India[J]. Int J Hepatol,2016,2016:4390434.
[9] Yazdanpanah S, Geramizadeh B, Nikeghbalian S, et al.Hepatocellular carcinoma and its precursors in 103 HBV-related cirrhotic explanted livers: A study from south Iran[J]. Hepat Mon,2016,16(8):e38584.
[10] International Working Party.Terminology of nodular he-patocellular lesions[J]. Hepatology,1995,22(3):983-993.
[11] International Consensus Group for Hepatocellular Neoplasia the International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia[J]. Hepatology,2009, 49(2):658-664.
[12] Park YN, Kojiro M, Di Tommaso L, et al.Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules[J]. Cancer,2007,109(5):915-923.
[13] Sciarra A, Di Tommaso L, Nakano M, et al.Morphophenotypic changes in human multistep hepatocarcinogenesis with translational implications[J]. J Hepatol,2016,64(1):87-93.
[14] Paschoal JP, Bernardo V, Canedo NH, et al.Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression[J]. BMC Cancer,2014,14:72.
[15] Kudo M.Multistep human hepatocarcinogenesis: correlation of imaging with pathology[J]. J Gastroenterol,2009, 44(19):112-118.
[16] Serste T, Barrau V, Ozenne V, et al.Accuracy and dis-agreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy[J]. He-patology,2012,55(3):800-806.
[17] Kojiro M.Diagnostic discrepancy of early hepatocellular carcinoma between Japan and West[J]. Hepatol Res,2007,37(Suppl 2):S121-S124.
[18] Di Tommaso L, Franchi G, Park YN, et al.Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis[J]. Hepatology,2007, 45(3):725-734.
[19] Cai MY, Tong ZT, Zheng F, et al.EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies[J]. Gut,2011, 60(7):967-976.
[20] Yao DF, Dong ZZ, Yao M.Specific molecular markers in hepatocellular carcinoma[J]. Hepatobiliary Pancreat Dis Int,2007,6(3):241-247.
[21] Jin GZ, Li Y, Cong WM, et al.iTRAQ-2DLC-ESI-MS/MS based identification of a new set of immunohistochemical biomarkers for classification of dysplastic nodules and small hepatocellular carcinoma[J]. J Proteome Res,2011, 10(8):3418-3428.
[22] Di Tommaso L, Sangiovanni A, Borzio M, et al.Advanced precancerous lesions in the liver[J]. Best Pract Res Clin Gastroenterol,2013,27(2):269-284.
[23] Borzio M, Fargion S, Borzio F, et al.Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development[J]. J Hepatol,2003,39(2):208-214.
[24] Kobayashi M, Ikeda K, Hosaka T, et al.Dysplastic no-dules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis[J]. Cancer,2006,106(3):636-647.
[25] Seki S, Sakaguchi H, Kitada T, et al.Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study[J]. Clin Cancer Res,2000,6(9):3469-3473.
[26] Okuda T, Wakasa K, Kubo S, et al.Clonal analysis of hepatocellular carcinoma and dysplastic nodule by methylation pattern of X-chromosome-linked human androgen receptor gene[J]. Cancer Lett,2001,164(1):91-96.
[27] Aihara T, Noguchi S, Sasaki Y, et al.Clonal analysis of precancerous lesion of hepatocellular carcinoma[J]. Gastroenterology,1996,111(2):455-461.
[28] Paradis V, Laurendeau I, Vidaud M, et al.Clonal analysis of macronodules in cirrhosis[J]. Hepatology,1998,28(4):953-958.
[29] Sun M, Eshleman JR, Ferrell LD, et al.An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region[J]. Hepatology,2001,33(6):1415-1424.
[30] Nam SW, Park JY, Ramasamy A, et al.Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling[J]. Hepatology,2005,42(4):809-818.
[31] Kang HJ, Chung DH, Sung CO, et al.SHP2 is induced by the HBx-NF-kappaB pathway and contributes to fibrosis during human early hepatocellular carcinoma development[J]. Oncotarget,2017,8(16):27263-27276.
[32] Shim YH, Yoon GS, Choi HJ, et al.p16 Hypermethylation in the early stage of hepatitis B virus-associated he-patocarcinogenesis[J]. Cancer Lett,2003,190(2):213-219.
[33] Frau M, Feo F, Pascale RM.Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis[J]. J He-patol,2013,59(4):830-841.

肝异型增生结节的研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	马婧嶔, 杨敏捷, 颜志平. 精细TACE的治疗目标与栓塞终点[J]. 外科理论与实践, 2022, 27(02): 131-133.
[2]	孙惠川. 肝细胞癌转化治疗的现状与展望[J]. 外科理论与实践, 2022, 27(02): 134-138.
[3]	张希昊, 章馨允, 曹曼卿, 张金梁, 王华琪, 张苏, 付周, 王鲁, 张倜. 肝细胞癌的抗血管生成免疫联合介入治疗：肝动脉灌注化疗与化疗栓塞疗效的比较[J]. 外科理论与实践, 2022, 27(02): 152-157.
[4]	管涛(综述), 张倜, 王鲁(审校). 肝细胞癌肺转移的潜在机制和治疗进展[J]. 外科理论与实践, 2022, 27(02): 180-184.
[5]	黄纪伟, 邱国腾, 曾勇. 肝细胞癌外科治疗进展[J]. 外科理论与实践, 2022, 27(02): 113-118.
[6]	冯浩, 吕子成, 夏强. 肝癌肝移植全过程管理及治疗进展[J]. 外科理论与实践, 2022, 27(02): 119-122.
[7]	吴城孝, 方婕, 周霁川, 肖永胜, 张晓光. 基于TCGA数据库肝细胞癌microRNA-324-5p表达与预后危险因素分析[J]. 外科理论与实践, 2021, 26(03): 249-253.
[8]	张勇强, 张倜, 孔银龙, 侯振宇, 李慧锴, 崔云龙, 宋天强, 李强. 术中出血对早期肝细胞癌病人围术期及预后的影响[J]. 外科理论与实践, 2018, 23(04): 342-345.
[9]	侯振宇, 孔银龙, 张勇强, 朱科云, 杨雪娇, 陈平, 李慧锴, 崔云龙, 宋天强, 李强, 张倜. 术前白细胞计数预测肝切除治疗超“米兰标准”肝细胞癌病人的预后[J]. 外科理论与实践, 2018, 23(04): 358-362.
[10]	肖永胜, 周俭. 非酒精性脂肪性肝病与肝细胞癌[J]. 外科理论与实践, 2018, 23(03): 210-213.
[11]	佟辉, 张家强, 祝哲诚, 彭承宏, 李涛. 超“UCSF标准”肝细胞癌肝移植术前经肝动脉化疗栓塞的疗效[J]. 外科理论与实践, 2018, 23(03): 241-246.
[12]	高志慧, 柏斗胜. 精准医学时代肝细胞癌破裂出血的诊治[J]. 外科理论与实践, 2018, 23(03): 217-220.
[13]	李涛, 祝哲诚, 彭承宏. 肝移植“精准”治疗原发性肝脏恶性肿瘤[J]. 外科理论与实践, 2018, 23(03): 200-204.
[14]	祝桂琦, 王彪, 杨怡, 代智. γδT细胞在肝细胞癌中作用的研究进展[J]. 外科理论与实践, 2018, 23(03): 289-292.
[15]	雷波,. 健康体检者胃癌及其癌前病变胃镜检查结果分析[J]. 内科理论与实践, 2016, 11(05): 313-315.